Induction of TFF1 gene expression in pancreas overexpressing transforming growth factor α

Gut

Volumn 45, Issue 1, 1999, Pages 105-111

  Ebert, M P A ^a   Hoffmann, J ^a   Haeckel, C ^a   Rutkowski, K ^a   Schmid, R M ^b   Wagner, M ^b   Adler, G ^b   Schulz, H U ^a   Roessner, A ^a   Hoffmann, W ^a   Malfertheiner, P ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Expression; Fibrosis; Pancreatitis; PS2; TFF peptides; Transforming growth factor

Indexed keywords

TRANSFORMING GROWTH FACTOR ALPHA; TREFOIL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CHRONIC PANCREATITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FIBROSIS; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0033007055     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.45.1.105     Document Type: Article

References (44)

1. 1 Korc M, Schmiegel W. Chronic pancreatitis. Curr Opin Gastroenterol 1994;10:502-6.
2. 2 DiMagno EP, Layer P, Clain JE. Chronic pancreatitis. In: Go VLW, ed. The pancreas, pathology, and disease. New York: Raven Press, 1993:665-706.
3. 3 Oertel JE, Heffess CS, Oertel YC. Pancreas. In: Sternberg SS, ed. Diagnostic surgical pathology. New York: Raven Press, 1993:57-93.
4. 4 Elsässer HP, Adler G, Kern HF. Fibroblast structure and function during regeneration from hormone-induced acute pancreatitis in the rat. Pancreas 1989;4:169-78.
5. 5 Friess H, Yamanaka Y, Büchler M, et al. Increased expression, of acidic and basic fibroblast growth factors in chronic pancreatitis. Am J Pathol 1994;144:117-28.
6. 6 Korc M, Friess H, Yamanaka Y, et al. Chronic pancreatitis is associated with increased levels of the epidermal growth factor receptor, TGF-α, and phospholipase-C gamma. Gut 1994;35:1468-73.
7. 7 Friess H, Yamanaka Y, Büchler M, et al. A subgroup of patients with chronic pancreatitis overexpress the c-erb B-2 protooncogene. Ann Surg 1994;220:183-92.
8. 8 Ebert M, Kasper HU, Hernberg S, et al. Overexpression of platelet-derived growth factor (PDGF) B chain and type β PDGF receptor in human chronic pancreatitis. Dig Dis Sci 1998;43:567-74.
9. 9 Bockman DE, Merlino G, Cytological changes in the pancreas of transgenic mice overexpressing transforming growth factor-α, Gastroenterology 1992;103:1883-92.
10. 10 Wright NA, Hoffmann W, Otto WR, et al. Rolling in the clover: trefoil factor family (TFF)-domain peptides, cell migration and cancer. FEBS Lett 1997;408:121-3.
11. 11 Hoffmann W, Hauser F. The P-domain or trefoil motif: a role in renewal and pathology of mucous epithelia? Trends Biochem Sci 1993;18:239-43.
12. 12 Williams GR, Wright NA. Trefoil factor family domain peptides. Virchows Arch 1997;431:299-304.
13. 13 Thim L. Trefoil peptides: from structure to function, Cellular and Molecular Life Sciences 1997;53:888-903.
14. 14 Sands BE, Podolsky DK. The trefoil peptide family. Annu Rev Physiol 1996;58:253-73.
15. 15 Wright N, Poulsom R, Stamp GWH, et al. Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol 1990;162:279-84.
16. 16 Jakowlew SB, Breathnach R, Jeltsch JM, et al. Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7. Nucleic Acids Res 1984;12:2861-78.
17. 17 Nunez AM, Berry M, Imler JL, et al. The 5′ flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumor promotor (TPA), the c-Ha-ras oncoprotein and the c-jun protein. EMBO J 1989;8:823-9.
18. 18 Dante R, Ribieras S, Baldasini S, et al. Expression of an estrogen-induced breast cancer-associated protein (pS2) in benign and malignant human ovarian cysts. Lab Invest 1994;71:188-92.
19. 19 Henry JA, Piggott NH, Mallick UK, et al. pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response. Br J Cancer 1991;63:615-22.
20. 20 Collier JD, Bennett MK, Bassendine MF, et al. Immunolocalization of pS2, a putative growth factor, in pancreatic carcinoma. J Gastroenterol Hepatol 1995;10:396-400.
21. 21 Wright NA. The expression of growth factors in the pancreas in chronic pancreatitis. Digestion Surgery 1994;11: 141-6.
22. 22 Dignass A, Lynch-Devaney K, Kindon H, et al. Trefoil peptides promote epithelial migration through a transforming growth factor-β independent pathway. J Clin Invest 1994;94:376-83.
23. 23 Playford RJ, Marchbank T, Chinery R, et al. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology 1995;108:108 16.
24. 24 Chinery R, Playford RJ. Combined intestinal trefoil factor and epidermal growth factor is prophylactic against indomethacin-induced gastric damage in the rat. Clin Sci 1995;88:401-3.
25. 58 of human pS2 plays a key role in the stimulation of healing in vitro and in vivo [abstract], Gut 1997;41:A45.
26. 26 Lefebvre O, Chenard MP, Masson R, et al. Gastric mucosa abnormalities and the tumorigenesis in mice lacking the pS2 trefoil protein. Science 1996;274:259-62.
27. 27 Bockman DE, Boydston WR, Anderson MC. Origin of tubular complexes in human chronic pancreatitis. Am J Surg 1982;144:243-9.
28. 28 Wagner M, Lührs H, Klöppel G, et al. Malignant transformation of duct-like cells originating from acini in TGFα transgenic mice. Gastroenterology 1998;115:1254 62.
29. 29 Parsa I, Longnecker DS, Scarpelli DG, et al. Ductal metaplasia of human exocrine pancreas and its association with carcinoma. Cancer Res 1985;45:1285-90.
30. 30 Sandgren EP, Leuttecke NC, Palmiter RD, et al. Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma nf the breast. Cell 1990;61:1121-35.
31. 31 Klöppel G, Maillet B. Pathology of acute and chronic pancreatitis. Pancreas 1993;8:659-70.
32. 32 Ebert M, Yokoyama M, Kobrin MS, et al. Induction and expression of amphiregulin in human pancreatic cancer. Cancer Res 1994;54:3959-62.
33. 33 Jeltsch JM, Roberts M, Schatz C, et al. Structure of the human oestrogen-responsive gene ps2. Nucleic Acids Res 1987;15:1401-11.
34. 34 Lefebvre O, Wolf C, Kedinger M, at al. The mouse one P-domain (pS2) and two P-domain (mSP) genes exhibit distinct patterns of expression. J Cell Biol 1993;122:191-8.
35. 35 Dallman MJ, Larsen CP, Morris PJ, Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med 1991;174:493-6.
36. 36 Balmain A, Krumlauf R, Vass JK, et al. Cloning and characterization of the abundant cytoplasmic 7S RNA from mouse cells. Nucleic Acids Res 1982;10:4259-77.
37. 37 Piggott NH, Henry JA, May FEB, et al. Antipeptide antibodies against the pNR-2 oestrogen-regulated protein of human breast cancer cells and detection of pNR-2 expression in normal tissues by immunohisrochemsitry. J Phatol 1991;163:95-104.
38. 38 Henry PA, Bennett MK, Piggott NH, et al. Expression of the pNR-2/pS2 protein in diverse human epithelial tumours. Br J Cancer 1991;64:677-82.
39. 39 Arias AE, Bendayan M. Differentiation of pancreatic acinar cells into duct-like cells in vitro. Lab Invest 1993;69:518-30.
40. 40 Korc M. Role of growth factors in pancreatic cancer. Surg Oncol Clin North Am 1998;7:25-41.
41. 41 Welter C, Theisinger B, Seitz G, et al. Association of the spasmolytic polypeptide and an estrogen-induced breast cancer protein (pS2) with human pancreatic carcinoma. Lab Invest 1992;66:187-92.
42. 42 Wright NA, Pike C, Elia G. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature 1990;343:82-5.
43. 43 Goldenring JR, Poulsom R, Ray GS, et al. Expression of trefoil peptides in the gastric mucosa of transgenic mice overexpressing transforming growth factor-α, Growth Factors 1996;13:111-19.
44. 44 Cook GA, Yeormans ND, Giraud AS. Temporal expression of trefoil peptides in the TGF-alpha knockout mouse after gastric ulceration. Am J Physiol 1997;272:G1540-9.